The Opportunity: -PLEASE APPLY WITH AN ENGLISH CV- VWR, part of the Avantor Group, is a leading provider of advanced solutions for science and industry, supporting customers worldwide in the pharmaceutical, biotechnology, chemical, and materials science sectors.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)